Asian stock fell slightly on Friday, failing to catch a broader global rally as the investor mood in the region shifted to broader caution about the economic outlook and as post-Brexit worries weighed.
A new potential roadblock to a US$900 billion coronavirus economic relief bill emerged in the US Congress on Thursday as some Senate Republicans insisted on language ensuring that expiring Federal Reserve lending programs cannot be revived.
After months of feuding, U.S. congressional negotiations over final details of a US$900 billion COVID-19 aid bill advanced, although it was unclear whether the work could be completed before a fast approaching weekend deadline.
A new potential roadblock to a US$900 billion coronavirus economic relief bill emerged in the U.S. Congress on Thursday as some Senate Republicans insisted on language ensuring that expiring Federal Reserve lending programs cannot be revived.
Microsoft was hacked as part of the suspected Russian campaign that has hit multiple U.S. government agencies by taking advantage of the widespread use of software from SolarWinds Corp, according to people familiar with the matter.
Rayban maker EssilorLuxottica said on Thursday it has rejigged an executive power sharing arrangement put in place when the company was created by a merger in 2018, promoting two internal managers to the top executive roles.
With time running out on a loan program that had seen little use so far, U.S. small- and mid-sized businesses are tapping into the Federal Reserve's Main Street Lending Program at a record pace.
Microsoft was hacked as part of the suspected Russian campaign that has hit multiple U.S. government agencies by taking advantage of the widespread use of software from SolarWinds Corp, according to people familiar with the matter.
Twitter is planning to create a new type of account for bots next year that will identify them as automated, the company said in a blog post on Thursday finalizing plans for a reboot of its long-paused verification program.
The U.S. Securities and Exchange Commission sued Decision Diagnostics Corp and its chief executive for allegedly misleading investors by promising the biotechnology company could test for COVID-19 with a finger-prick of blood and provide accurate results in less than one minute.
